The MAP kinase Pmk1 and protein kinase A are required for rotenone resistance in the fission yeast, Schizosaccharomyces pombe

Biochemical and Biophysical Research Communications
Yiwei WangS Marcus

Abstract

Rotenone is a widely used pesticide that induces Parkinson's disease-like symptoms in rats and death of dopaminergic neurons in culture. Although rotenone is a potent inhibitor of complex I of the mitochondrial electron transport chain, it can induce death of dopaminergic neurons independently of complex I inhibition. Here we describe effects of rotenone in the fission yeast, Schizosaccharomyces pombe, which lacks complex I and carries out rotenone-insensitive cellular respiration. We show that rotenone induces generation of reactive oxygen species (ROS) as well as fragmentation of mitochondrial networks in treated S. pombe cells. While rotenone is only modestly inhibitory to growth of wild type S. pombe cells, it is strongly inhibitory to growth of mutants lacking the ERK-type MAP kinase, Pmk1, or protein kinase A (PKA). In contrast, cells lacking the p38 MAP kinase, Spc1, exhibit modest resistance to rotenone. Consistent with these findings, we provide evidence that Pmk1 and PKA, but not Spc1, are required for clearance of ROS in rotenone treated S. pombe cells. Our results demonstrate the usefulness of S. pombe for elucidating complex I-independent molecular targets of rotenone as well as mechanisms conferring resistance to ...Continue Reading

References

Apr 1, 1976·Environmental Health Perspectives·S B Soloway
Mar 1, 1990·Journal of Neurochemistry·Anthony H V SchapiraC D Marsden
Sep 29, 1989·Biochemical and Biophysical Research Communications·Y MizunoY Kagawa
Mar 30, 1974·Experimental Cell Research·B R BrinkleyG M Fuller
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·M P YaffeP Nurse
Mar 17, 1997·The EMBO Journal·T Zaitsevskaya-Carter, J A Cooper
Jun 19, 1998·Biochimica Et Biophysica Acta·M Degli Esposti
Jun 19, 1998·Biochimica Et Biophysica Acta·P Lümmen
Dec 2, 2000·Nature Neuroscience·Ranjita BetarbetJ Timothy Greenamyre
Mar 14, 2001·Biochimica Et Biophysica Acta·T Joseph-HorneP M Wood
Jan 17, 2003·Molecular Biology of the Cell·Dongrong ChenJürg Bähler
Jul 3, 2003·Biochimica Et Biophysica Acta·Judy HirstJohn E Walker
Aug 14, 2003·Parkinsonism & Related Disorders·J Timothy GreenamyreTodd B Sherer
Apr 22, 2005·Journal of Molecular Biology·Toni GabaldónMartijn A Huynen
Jul 29, 2006·The EMBO Journal·Mark J BarsoumElla Bossy-Wetzel
Feb 15, 2007·Journal of Cell Science·Giovanni BenardRodrigue Rossignol
Nov 16, 2007·Molecular Biology of the Cell·Dongrong ChenJürg Bähler
Dec 21, 2007·Lancet Neurology·Anthony H V Schapira
Sep 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Won-Seok ChoiZhengui Xia
Apr 1, 2009·Journal of the Neurological Sciences·Masahiro Nagao, Hideaki Hayashi
May 4, 2010·Eukaryotic Cell·Ana CastroArnaldo Videira

Related Concepts

Pmk1 protein, S pombe
Spc1 protein, S pombe
Mitochondria
Rotenone
Schizosaccharomyces pombe
Reactive Oxygen Species
Cyclic AMP-Dependent Protein Kinases
Mitogen-Activated Protein Kinases
Drug Resistance, Multiple, Fungal
Schizosaccharomyces pombe Proteins

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.